A detailed history of Gsa Capital Partners LLP transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 334,092 shares of SENS stock, worth $93,545. This represents 0.01% of its overall portfolio holdings.

Number of Shares
334,092
Holding current value
$93,545
% of portfolio
0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$0.32 - $0.49 $106,909 - $163,705
334,092 New
334,092 $117,000
Q3 2023

Nov 15, 2023

SELL
$0.5 - $1.05 $173,186 - $363,691
-346,373 Reduced 63.0%
203,406 $122,000
Q2 2023

Aug 14, 2023

BUY
$0.55 - $0.89 $302,378 - $489,303
549,779 New
549,779 $417,000
Q4 2022

Feb 13, 2023

BUY
$0.96 - $1.34 $74,580 - $104,101
77,688 Added 462.1%
94,500 $97,000
Q3 2022

Nov 14, 2022

SELL
$1.02 - $2.23 $332,638 - $727,238
-326,116 Reduced 95.1%
16,812 $22,000
Q2 2022

Aug 09, 2022

BUY
$0.94 - $1.94 $111,094 - $229,280
118,186 Added 52.59%
342,928 $353,000
Q1 2022

May 11, 2022

SELL
$1.54 - $3.71 $162,237 - $390,844
-105,349 Reduced 31.92%
224,742 $443,000
Q4 2021

Feb 14, 2022

BUY
$2.58 - $3.91 $851,634 - $1.29 Million
330,091 New
330,091 $881,000
Q4 2020

Feb 03, 2021

SELL
$0.36 - $0.95 $58,987 - $155,660
-163,853 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$0.36 - $0.53 $3,359 - $4,945
-9,331 Reduced 5.39%
163,853 $63,000
Q2 2020

Aug 11, 2020

BUY
$0.39 - $0.69 $61,823 - $109,379
158,521 Added 1081.1%
173,184 $68,000
Q1 2020

May 12, 2020

SELL
$0.56 - $1.62 $76,269 - $220,637
-136,196 Reduced 90.28%
14,663 $9,000
Q4 2019

Feb 12, 2020

BUY
$0.83 - $1.3 $125,212 - $196,116
150,859 New
150,859 $138,000
Q3 2018

Nov 13, 2018

SELL
$3.4 - $4.84 $221,425 - $315,205
-65,125 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$3.03 - $4.98 $197,328 - $324,322
65,125 New
65,125 $268,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $130M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.